查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1641812

全球血糖儀市場按類型和最終用戶分類 - 機會分析和行業預測，2024 年至 2033 年

Glucose Meter Market By Type (Traditional Glucose Meters, Smart Glucose Meters) , By End User (Hospitals, Clinics, Home Care Settings) : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 216 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

血糖儀市場規模預計在 2023 年達到 10 億美元，到 2033 年將達到 17 億美元，2024 年至 2033 年的複合年成長率為 5.4%。

血糖儀市場-IMG1

血糖儀，也稱為血糖儀，是一種用於測量血液中葡萄糖濃度的攜帶式醫療設備。糖尿病患者通常使用它們來監測血糖值，幫助他們有效地管理病情。該設備需要刺穿手指以獲取少量血樣，然後進行分析以提供即時血糖讀數。

全球血糖儀市場正在經歷強勁成長，原因包括公眾對定期血糖值監測和早期診斷重要性的認知不斷提高，以及久坐的生活方式和不健康的飲食習慣導致糖尿病患病率急劇上升。根據國際糖尿病聯盟（IDF）2021年發布的調查顯示，全球約有5.37億成年人（20-79歲）患有糖尿病。預計到2030年這數字將達到6.43億，到2045年將達到7.83億。這凸顯了對血糖儀持續監測血糖濃度的迫切需求。此外，人們對家庭醫療保健解決方案的日益偏好推動了對可攜式和易於使用的血糖儀的需求，從而推動了市場成長。此外，老年人口的快速增加將成為全球市場的主要動力。這是因為老齡化人口更容易患糖尿病和相關併發症，從而增加了對有效血糖監測解決方案的需求。世界衛生組織（WHO）發布的2024年調查顯示，老年人口數量將從2020年的10億增加到2030年的14億。此外，到2050年，80歲及以上人口數量預計將達到4.26億人。新興市場醫療保健基礎設施的改善和可支配收入的增加進一步增加了血糖監測設備的使用機會，從而推動了市場的成長。然而，連續血糖監測儀等先進血糖監測系統的高成本正在抑制市場的成長。此外，缺乏對糖尿病管理和定期血糖監測重要性的認知限制了對血糖儀的需求。相反，連續血糖監測儀、智慧型手機儀表和非侵入式設備等創新血糖監測技術的發展正在提高準確性、便利性和易用性。預計這些發展將為預測期內全球市場的擴張開闢新的途徑。

全球血糖儀產業分為類型、最終用戶和地區。根據類型，市場分為傳統血糖儀和智慧血糖儀。根據最終用戶，市場分為醫院、診所和居家醫療。按地區分析，涵蓋北美、歐洲、亞太、拉丁美洲以及中東和非洲。

主要發現

按類型分類，傳統血糖儀預計將在 2024 年至 2033 年期間佔據市場主導地位。

根據最終用戶，醫院部門預計在預測期內呈現最高成長。

根據地區，預計未來幾年血糖儀市場在北美將呈現強勁成長。

此報告可自訂。 （需要額外的費用和時間表。）

  • 監管指南
  • 根據客戶興趣提供額外的公司簡介
  • 導入/匯出分析/資料
  • 贖回情況

目錄

第 1 章 簡介

第 2 章執行摘要

第3章 市場狀況

  • 市場定義和範圍
  • 主要發現
    • 重大投資機會
    • 關鍵成功策略
  • 波特五力分析
  • 市場動態
    • 驅動程式
    • 限制因素
    • 機會

第4章 血糖機市場類型

  • 市場概況
  • 傳統血糖儀
  • 智慧型血糖儀

第 5 章 血糖儀市場（依最終用戶）

  • 市場概況
  • 醫院
  • 診所
  • 居家醫療

6. 血糖儀市場（按地區）

  • 市場概況
  • 北美洲
    • 主要市場趨勢和機遇
    • 美國血糖儀市場
    • 加拿大血糖機市場
    • 墨西哥的血糖儀市場
  • 歐洲
    • 主要市場趨勢和機遇
    • 法國血糖機市場
    • 德國血糖儀市場
    • 義大利血糖機市場
    • 西班牙血糖儀市場
    • 英國血糖儀市場
    • 其他歐洲國家血糖儀市場
  • 亞太地區
    • 主要市場趨勢和機遇
    • 中國血糖儀市場
    • 日本血糖儀市場
    • 印度血糖儀市場
    • 韓國血糖儀市場
    • 澳洲血糖儀市場
    • 其他亞太地區血糖儀市場
  • 拉丁美洲、中東和非洲
    • 主要市場趨勢和機遇
    • 巴西血糖儀市場
    • 南非血糖儀市場
    • 沙烏地阿拉伯血糖儀市場
    • 拉丁美洲、中東和非洲其他地區的血糖儀市場

第7章 競爭格局

  • 介紹
  • 關鍵成功策略
  • 前 10 家公司的產品映射
  • 競爭儀錶板
  • 競爭熱圖
  • 2023年主要企業的定位

第8章 公司簡介

  • B. Braun SE
  • F. Hoffmann-La Roche Ltd
  • AgaMatrix, Inc
  • Ascensia Diabetes Care
  • LifeScan IP Holdings, LLC.
  • Medtronic
  • Dexcom, Inc.
  • Ypsomed.
  • Abbott Laboratories
  • Terumo Corporation
簡介目錄
Product Code: A324427

The glucose meter market was valued at $1.0 billion in 2023, and is projected to reach $1.7 billion by 2033, growing at a CAGR of 5.4% from 2024 to 2033.

Glucose Meter Market - IMG1

A glucose meter, also known as a glucometer, is a portable medical device designed to measure the concentration of glucose in the blood. It is commonly used by individuals with diabetes to monitor their blood sugar levels, helping them manage their condition effectively. The device requires a small blood sample, obtained via a finger prick, which is then analyzed to provide real-time glucose readings.

The global glucose meter market is witnessing robust growth due to factors such as increase in public awareness about the importance of regular blood glucose monitoring and early diagnosis and alarming rise in prevalence of diabetes driven by sedentary lifestyle and unhealthy diets. As per a study published in 2021 by the International Diabetes Federation (IDF), approximately 537 million adults (20-79 years) were suffering from diabetes. This number is estimated to reach 643 million by 2030 and 783 million by 2045. This highlights the urgent need for glucose meters for continuous monitoring of glucose levels. In addition, rise in preference for home-based healthcare solutions has driven the demand for portable and easy-to-use glucose meters, thereby fostering the market growth. Furthermore, surge in geriatric population acts as a key driving force of the global market. This is attributed to the fact that the aging population is more susceptible to diabetes and related complications, creating a growing need for efficient glucose monitoring solutions. A 2024 study published by the World Health Organization revealed that the number of aged individuals will increase from 1 billion in 2020 to 1.4 billion by 2030. Moreover, the number of individuals aging 80 years and older is estimated to reach 426 million by 2050. Improved healthcare infrastructure and rise in disposable incomes in emerging markets have further enhanced access to glucose monitoring devices, driving the market growth. However, high cost associated with advanced glucose monitoring systems, such as continuous glucose monitors, restrains the market growth. In addition, lack awareness about diabetes management and the importance of regular glucose monitoring limits the demand for glucose meters. On the contrary, the development of innovative glucose monitoring technologies, such as continuous glucose monitors, smartphone-compatible meters, and non-invasive devices has enhanced accuracy, convenience, and user-friendliness. Such developments are expected to open new avenues for the expansion of the global market during the forecast period.

The global glucose meter industry is segmented into type, end user, and region. On the basis of type, the market is categorized into traditional glucose meters and smart glucose meters. Depending on end user, it is segregated into hospitals, clinics, and home care settings. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

By type, the traditional glucose meters segment is expected to dominate the market from 2024 to 2033.

On the basis of end user, the hospitals segment is anticipated to exhibit the highest growth during the forecast period.

Region wise, the blood glucose meter market is projected to show strong growth in North America in the coming years.

Competition Analysis

The major players operating in the global glucose meter market include B. Braun SE, F. Hoffmann-La Roche Ltd, AgaMatrix, Inc, Ascensia Diabetes Care, LifeScan IP Holdings, LLC., Medtronic, Dexcom, Inc., Ypsomed., Abbott Laboratories, and Terumo Corporation. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to sustain the intense competition and gain a strong foothold in the global market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Import Export Analysis/Data
  • Reimbursement Scenario

Key Market Segments

By Type

  • Traditional Glucose Meters
  • Smart Glucose Meters

By End User

  • Hospitals
  • Clinics
  • Home Care Settings

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • B. Braun SE
    • F. Hoffmann-La Roche Ltd
    • AgaMatrix, Inc
    • Ascensia Diabetes Care
    • LifeScan IP Holdings, LLC.
    • Medtronic
    • Dexcom, Inc.
    • Ypsomed.
    • Abbott Laboratories
    • Terumo Corporation

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: GLUCOSE METER MARKET, BY TYPE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Type
  • 4.2. Traditional Glucose Meters
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Smart Glucose Meters
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country

CHAPTER 5: GLUCOSE METER MARKET, BY END USER

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By End User
  • 5.2. Hospitals
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Clinics
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Home Care Settings
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country

CHAPTER 6: GLUCOSE METER MARKET, BY REGION

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By Region
  • 6.2. North America
    • 6.2.1. Key Market Trends and Opportunities
    • 6.2.2. Market Size and Forecast, By Type
    • 6.2.3. Market Size and Forecast, By End User
    • 6.2.4. Market Size and Forecast, By Country
    • 6.2.5. U.S. Glucose Meter Market
      • 6.2.5.1. Market Size and Forecast, By Type
      • 6.2.5.2. Market Size and Forecast, By End User
    • 6.2.6. Canada Glucose Meter Market
      • 6.2.6.1. Market Size and Forecast, By Type
      • 6.2.6.2. Market Size and Forecast, By End User
    • 6.2.7. Mexico Glucose Meter Market
      • 6.2.7.1. Market Size and Forecast, By Type
      • 6.2.7.2. Market Size and Forecast, By End User
  • 6.3. Europe
    • 6.3.1. Key Market Trends and Opportunities
    • 6.3.2. Market Size and Forecast, By Type
    • 6.3.3. Market Size and Forecast, By End User
    • 6.3.4. Market Size and Forecast, By Country
    • 6.3.5. France Glucose Meter Market
      • 6.3.5.1. Market Size and Forecast, By Type
      • 6.3.5.2. Market Size and Forecast, By End User
    • 6.3.6. Germany Glucose Meter Market
      • 6.3.6.1. Market Size and Forecast, By Type
      • 6.3.6.2. Market Size and Forecast, By End User
    • 6.3.7. Italy Glucose Meter Market
      • 6.3.7.1. Market Size and Forecast, By Type
      • 6.3.7.2. Market Size and Forecast, By End User
    • 6.3.8. Spain Glucose Meter Market
      • 6.3.8.1. Market Size and Forecast, By Type
      • 6.3.8.2. Market Size and Forecast, By End User
    • 6.3.9. UK Glucose Meter Market
      • 6.3.9.1. Market Size and Forecast, By Type
      • 6.3.9.2. Market Size and Forecast, By End User
    • 6.3.10. Rest Of Europe Glucose Meter Market
      • 6.3.10.1. Market Size and Forecast, By Type
      • 6.3.10.2. Market Size and Forecast, By End User
  • 6.4. Asia-Pacific
    • 6.4.1. Key Market Trends and Opportunities
    • 6.4.2. Market Size and Forecast, By Type
    • 6.4.3. Market Size and Forecast, By End User
    • 6.4.4. Market Size and Forecast, By Country
    • 6.4.5. China Glucose Meter Market
      • 6.4.5.1. Market Size and Forecast, By Type
      • 6.4.5.2. Market Size and Forecast, By End User
    • 6.4.6. Japan Glucose Meter Market
      • 6.4.6.1. Market Size and Forecast, By Type
      • 6.4.6.2. Market Size and Forecast, By End User
    • 6.4.7. India Glucose Meter Market
      • 6.4.7.1. Market Size and Forecast, By Type
      • 6.4.7.2. Market Size and Forecast, By End User
    • 6.4.8. South Korea Glucose Meter Market
      • 6.4.8.1. Market Size and Forecast, By Type
      • 6.4.8.2. Market Size and Forecast, By End User
    • 6.4.9. Australia Glucose Meter Market
      • 6.4.9.1. Market Size and Forecast, By Type
      • 6.4.9.2. Market Size and Forecast, By End User
    • 6.4.10. Rest of Asia-Pacific Glucose Meter Market
      • 6.4.10.1. Market Size and Forecast, By Type
      • 6.4.10.2. Market Size and Forecast, By End User
  • 6.5. LAMEA
    • 6.5.1. Key Market Trends and Opportunities
    • 6.5.2. Market Size and Forecast, By Type
    • 6.5.3. Market Size and Forecast, By End User
    • 6.5.4. Market Size and Forecast, By Country
    • 6.5.5. Brazil Glucose Meter Market
      • 6.5.5.1. Market Size and Forecast, By Type
      • 6.5.5.2. Market Size and Forecast, By End User
    • 6.5.6. South Africa Glucose Meter Market
      • 6.5.6.1. Market Size and Forecast, By Type
      • 6.5.6.2. Market Size and Forecast, By End User
    • 6.5.7. Saudi Arabia Glucose Meter Market
      • 6.5.7.1. Market Size and Forecast, By Type
      • 6.5.7.2. Market Size and Forecast, By End User
    • 6.5.8. Rest of LAMEA Glucose Meter Market
      • 6.5.8.1. Market Size and Forecast, By Type
      • 6.5.8.2. Market Size and Forecast, By End User

CHAPTER 7: COMPETITIVE LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top Winning Strategies
  • 7.3. Product Mapping Of Top 10 Player
  • 7.4. Competitive Dashboard
  • 7.5. Competitive Heatmap
  • 7.6. Top Player Positioning, 2023

CHAPTER 8: COMPANY PROFILES

  • 8.1. B. Braun SE
    • 8.1.1. Company Overview
    • 8.1.2. Key Executives
    • 8.1.3. Company Snapshot
    • 8.1.4. Operating Business Segments
    • 8.1.5. Product Portfolio
    • 8.1.6. Business Performance
    • 8.1.7. Key Strategic Moves and Developments
  • 8.2. F. Hoffmann-La Roche Ltd
    • 8.2.1. Company Overview
    • 8.2.2. Key Executives
    • 8.2.3. Company Snapshot
    • 8.2.4. Operating Business Segments
    • 8.2.5. Product Portfolio
    • 8.2.6. Business Performance
    • 8.2.7. Key Strategic Moves and Developments
  • 8.3. AgaMatrix, Inc
    • 8.3.1. Company Overview
    • 8.3.2. Key Executives
    • 8.3.3. Company Snapshot
    • 8.3.4. Operating Business Segments
    • 8.3.5. Product Portfolio
    • 8.3.6. Business Performance
    • 8.3.7. Key Strategic Moves and Developments
  • 8.4. Ascensia Diabetes Care
    • 8.4.1. Company Overview
    • 8.4.2. Key Executives
    • 8.4.3. Company Snapshot
    • 8.4.4. Operating Business Segments
    • 8.4.5. Product Portfolio
    • 8.4.6. Business Performance
    • 8.4.7. Key Strategic Moves and Developments
  • 8.5. LifeScan IP Holdings, LLC.
    • 8.5.1. Company Overview
    • 8.5.2. Key Executives
    • 8.5.3. Company Snapshot
    • 8.5.4. Operating Business Segments
    • 8.5.5. Product Portfolio
    • 8.5.6. Business Performance
    • 8.5.7. Key Strategic Moves and Developments
  • 8.6. Medtronic
    • 8.6.1. Company Overview
    • 8.6.2. Key Executives
    • 8.6.3. Company Snapshot
    • 8.6.4. Operating Business Segments
    • 8.6.5. Product Portfolio
    • 8.6.6. Business Performance
    • 8.6.7. Key Strategic Moves and Developments
  • 8.7. Dexcom, Inc.
    • 8.7.1. Company Overview
    • 8.7.2. Key Executives
    • 8.7.3. Company Snapshot
    • 8.7.4. Operating Business Segments
    • 8.7.5. Product Portfolio
    • 8.7.6. Business Performance
    • 8.7.7. Key Strategic Moves and Developments
  • 8.8. Ypsomed.
    • 8.8.1. Company Overview
    • 8.8.2. Key Executives
    • 8.8.3. Company Snapshot
    • 8.8.4. Operating Business Segments
    • 8.8.5. Product Portfolio
    • 8.8.6. Business Performance
    • 8.8.7. Key Strategic Moves and Developments
  • 8.9. Abbott Laboratories
    • 8.9.1. Company Overview
    • 8.9.2. Key Executives
    • 8.9.3. Company Snapshot
    • 8.9.4. Operating Business Segments
    • 8.9.5. Product Portfolio
    • 8.9.6. Business Performance
    • 8.9.7. Key Strategic Moves and Developments
  • 8.10. Terumo Corporation
    • 8.10.1. Company Overview
    • 8.10.2. Key Executives
    • 8.10.3. Company Snapshot
    • 8.10.4. Operating Business Segments
    • 8.10.5. Product Portfolio
    • 8.10.6. Business Performance
    • 8.10.7. Key Strategic Moves and Developments